跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CEPACOL EXTRA STRENGTH ORANGE CITRUS LOZENGE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CEPACOL EXTRA STRENGTH ORANGE CITRUS LOZENGE
Authorized
STANDARD
CEPACOL EXTRA STRENGTH ORANGE CITRUS LOZENGE
COMBE INCORPORATED
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
f2a5de9ec9f26fdd
Company
COMBE INCORPORATED
Type
Standard
Approval Details
Approval Id
f2a5de9ec9f26fdd
Drug Approval Canada Name
CEPACOL EXTRA STRENGTH ORANGE CITRUS LOZENGE
Product Name
CEPACOL EXTRA STRENGTH ORANGE CITRUS LOZENGE
Status
Cancelled Post Market
Status Date
2009-07-09
Original Market Date
2004-09-01
Din
02248741
Drug Class
Human
Dosage Form
Lozenge
Route Of Administration
Oral
Schedule
OTC
Ahfs
52:16.00
Atc Original
R02AA06 CETYLPYRIDINIUM
Atc Name
r 02 aa 06
Aig Number
0204959005
Company Name
COMBE INCORPORATED
Company Address
1101 Westchester Avenue, White Plains, New York, United States, 10604-3597
Company Detail Path
/organization/combe-incorporated
Company Information
Pharmaceutical Company Name
COMBE INCORPORATED
Country Name
United States
Province Name
Washington
City Name
lynnwood,washington,country_us
Address
19020 33RD Ave W Ste 240
Active Ingredients
BENZOCAINE
10.0 MG
CETYLPYRIDINIUM CHLORIDE
1.45 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
f2a5de9ec9f26fdd
Type
Standard
Back to Health Canada Approvals
